GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Libra Infusions Ltd (DHA:LIBRAINFU) » Definitions » 3-Year EBITDA Growth Rate

Libra Infusions (DHA:LIBRAINFU) 3-Year EBITDA Growth Rate : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Libra Infusions 3-Year EBITDA Growth Rate?

Libra Infusions's EBITDA per Share for the six months ended in . 20 was BDT0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Libra Infusions's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Libra Infusions's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Libra Infusions's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Libra Infusions's 3-Year EBITDA Growth Rate falls into.



Libra Infusions 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Libra Infusions  (DHA:LIBRAINFU) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Libra Infusions 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Libra Infusions's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Libra Infusions (DHA:LIBRAINFU) Business Description

Traded in Other Exchanges
N/A
Address
I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.

Libra Infusions (DHA:LIBRAINFU) Headlines

No Headlines